A case of fulminant viral hepatitis type B in the late stage of pregnancy was successfully treated with glucagon-insulin therapy, corticosteroids and other drugs. A 26-year-old female (housewife and primipara) suddenly developed severe hepatic dysfunction and disturbance of consciousness at the 36th week of pregnancy. Sequential blood examinations revealed early response to HBs antibody and del...

The relationship between acute myeloid leukemia (AML), acute lymphocytic leukemia, chronic myeloid leukemia (CML), and refractory anemia with excess of blasts (RAEB) and antibodies to human T-cell lymphotropic virus types I and II (HTLV-I and HTLV-II), and hepatitis B virus and hepatitis C virus (HCV) was investigated in a multicenter case-control study. There were 431 cases enrolled in the stu...

conclusions this study showed a low rate of isolated anti-hbc and occult hbv infection in hd patients. it can be due to improvement of people’s knowledge about hbv transmission routes, hbv vaccination of hd patients and regular surveillance of hbv infection. results a hundredpatients with a mean age of 58.5 ± 16.1 years were enrolled in this study. in total, 56.7% were male and 43.3% female. an...

one of the most serious kinds of hepatitis is hepatitis b. this condition is more common than aids, and is 100 time more contagious. in iran the most common cause of acute and chronic hepatitis, liver cirrhosis, and also hepatocellar carcinoma in adults, is hepatitis b. more than two billion people are infected and more than 350 million of individuals are carriers of this virus in the entire wo...

INTRODUCTION Recombinant hepatitis B vaccine was introduced in 1986 and has gradually replaced the plasma-derived hepatitis B vaccine. No published data are available on the immunogenicity of hepatitis B vaccines in Nigerians. The current study aimed to evaluate protective sero-conversion rates after vaccination with Shanvac-B rDNA hepatitis B vaccine in Nigerian subjects between January and Se...

Four hundred and fifty three healthy children immunized with a course of hepatitis B vaccine beginning at birth were tested at 10-11 years of age for persistence of anti-hepatitis B-S antigen antibody (anti-HBs); and responses of children without protective antibody to different doses of hepatitis B vaccine booster were evaluated. Although nearly 42% of them were not seroprotected, but most of ...

     Thimerosal, which is approximately 50% mercury by weight is a preservative widely used in vaccines since the 1930’s. It meets the requirements for a preservative as set forth by Pharmacopeia challenge test and has been shown to be effective against a broad spectrum of pathogens. In July 1999, the Public Health Service agencies and vaccine manufacturers agreed that thimerosal should be redu...

aim : this study was designed to evaluate the frequency of antibody against these viruses in individuals attending the endoscopy ward of taleghani hospital tehran, iran. background : blood-borne viruses such as hepatitis b and hepatitis c virus and htlv-1 virus are among the world’s public health problems. hepatitis viruses cause liver problems and htlv-1 infection can lead to adult t-cell lymp...

Two patients with HBsAg positive chronic active hepatitis have been treated with human fibroblast interferon 10(7) units daily for two weeks. Before treatment, both patients had high levels of hepatitis B surface antigen, core antibody, and DNA-binding antibody in the blood and one patient had a fourfold rise in serum AST. During treatment there was a striking fall in the core antibody titre an...